-+ 0.00%
-+ 0.00%
-+ 0.00%

Yarrow Bioscience launches underwritten follow-on stock offering

PUBT·09/10/2026 20:03:20
Listen to the news
Yarrow Bioscience launches underwritten follow-on stock offering
  • Yarrow Bioscience launched an underwritten public offering of common stock, with pre-funded warrants available in lieu of shares.
  • Underwriters will have a 30-day option to buy up to 15% more shares at the offering price, net of discounts.
  • Proceeds earmarked for R&D across the pipeline, with remaining funds for general corporate purposes.
  • Jefferies, TD Cowen, Guggenheim Securities named joint bookrunners; LifeSci Capital set as lead manager.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yarrow Bioscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609101603BIZWIRE_USPR_____20260910_BW221537) on September 10, 2026, and is solely responsible for the information contained therein.